Cresco Labs Q3 EPS Lifted by Alliance Global Partners

Cresco Labs Inc. (OTCMKTS:CRLBF) – Equities research analysts at Alliance Global Partners lifted their Q3 2025 earnings per share estimates for shares of Cresco Labs in a report issued on Wednesday, March 12th. Alliance Global Partners analyst A. Grey now forecasts that the company will post earnings of ($0.02) per share for the quarter, up from their previous estimate of ($0.03). The consensus estimate for Cresco Labs’ current full-year earnings is ($0.20) per share. Alliance Global Partners also issued estimates for Cresco Labs’ Q4 2025 earnings at ($0.01) EPS, FY2025 earnings at ($0.09) EPS and FY2026 earnings at ($0.08) EPS.

Cresco Labs (OTCMKTS:CRLBF) last issued its quarterly earnings data on Friday, March 14th. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.01). Cresco Labs had a negative return on equity of 16.52% and a negative net margin of 9.15%. The business had revenue of $176.00 million during the quarter, compared to analyst estimates of $172.10 million.

Separately, Atb Cap Markets cut Cresco Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, December 9th. Three research analysts have rated the stock with a hold rating, one has issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, Cresco Labs has a consensus rating of “Moderate Buy” and an average price target of $3.00.

Cresco Labs Trading Down 0.8 %

OTCMKTS CRLBF opened at $0.73 on Monday. The stock has a market capitalization of $358.29 million, a price-to-earnings ratio of -3.67 and a beta of 1.79. The stock’s 50 day moving average price is $0.88 and its two-hundred day moving average price is $1.19. The company has a debt-to-equity ratio of 1.80, a quick ratio of 1.39 and a current ratio of 1.97. Cresco Labs has a 52 week low of $0.70 and a 52 week high of $2.60.

Cresco Labs Company Profile

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.